Applied Biochemistry and Biotechnology

, Volume 27, Issue 1, pp 45–54 | Cite as

Enzyme modification by MPEG with an amino acid or peptide as spacer arms

  • Luciana Sartore
  • Paolo Caliceti
  • Oddone Schiavon
  • Francesco M. Veronese


A method for the modification of enzymes by MPEG carrying an amino acid or peptide as a spacer arm is described and tested with aliphatic or aromatic side chains amino acids. The procedure involves MPEG activation byp-nitrophenylchloroformate for the amino acid or peptide coupling that is in turn activated for the protein binding.

The advantage of the method resides in the possibility to introduce proper reporter groups between the polymer and the protein as norleucine for a direct evaluation of the bound polymer chains, tryptophan for structural studies of the polymer-protein adduct, and radioactive amino acid for pharmacokinetic investigations.

The method was positively tested with arginase, ribonuclease, and superoxide dismutase as enzymes of therapeutic value.

Index Entries

Surface protein modifications monomethoxypolyethylene glycol amino acid or peptide derivatized MPEG enzymes for therapy arginase ribonucleases and superoxide dismutase 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abuchowski, A. and Davis, F. F. (1981), inEnzymes as Drugs, Holcenberg, J. S. and Roberts, J., ed., Wiley & Sons, pp 367-384.Google Scholar
  2. 2.
    Conforti, A., Franco, L., Milanino, R., Velco, G. P., Boccu, E., Largajolli, R., Schiavon, O. and Veronese, F. M. (1987),Pharmacol. Research Comunic. 19, 287.CrossRefGoogle Scholar
  3. 3.
    Veronese, F. M. (1989),Chimica Oggi 7, 53.Google Scholar
  4. 4.
    Yoshinga, K. and Harris, J. M. (1989),J. Bioactive Compatible Polymers 4, 17.CrossRefGoogle Scholar
  5. 5.
    Kopecek, J. and Duncan, R. (1987),J. Controlled Release 6, 315.CrossRefGoogle Scholar
  6. 6.
    Crook, E. M., Mathias, A. P. and Rabin, B. R. (1960),J. Biochem. 74, 234.Google Scholar
  7. 7.
    Paoletti, F., Aldinucci, D., Mocali, A. and Caparrini, A. (1986),Anal. Biochem. 154, 536.CrossRefGoogle Scholar
  8. 8.
    Snyder, S. L. and Sabocinsky, P. Z. (1975),Anal. Biochem. 64, 248.CrossRefGoogle Scholar
  9. 9.
    Sims, G. E. C. and Snape, T. J. (1980),Anal. Biochem. 107, 60.CrossRefGoogle Scholar
  10. 10.
    Visco, C, Benassi, C. A., Veronese, F. M., and Miglioli, P. A. (1987),II Farmaco 42, 549.Google Scholar
  11. 11.
    Caliceti, P., Schiavon, O., Mocali, A., and Veronese, F. M. (1989),II Farmaco 44, 711.Google Scholar
  12. 12.
    Veronese, F.M., Caliceti, P., Pastorino, A., Schiavon, O., Sartore, L., Banci, L., and Monsu Scolaro, L. (1989),J. Controlled Release 10, 145.CrossRefGoogle Scholar
  13. 13.
    Schiavon, O. et al. in preparastion.Google Scholar
  14. 14.
    Joppich, M., and Luisi, P. L. (1979),Makromol. Chem. 180, 1381.CrossRefGoogle Scholar
  15. 15.
    Brand, L. and Whithold, B. (1967),Methods Enzymol. 11, 776.CrossRefGoogle Scholar
  16. 16.
    Veronese, F. M., Sartore, L., Caliceti, P., Schiavon, O., Ranucci, E., and Ferruti, P. (1989),J. Bioactive Compatible Polymers (in press).Google Scholar
  17. 17.
    Hemant, N. J. (1988),Pharmaceutical Technology 12, 118.Google Scholar

Copyright information

© Humana Press Inc. 1991

Authors and Affiliations

  • Luciana Sartore
    • 1
  • Paolo Caliceti
    • 1
  • Oddone Schiavon
    • 1
  • Francesco M. Veronese
    • 1
  1. 1.Dipartimento di Scienze Farmaceutiche (Centro di Chimica del Farmaco e dei Prodotti Biologicamente Attivi del CUR)Universita di PadouaPadouaItaly

Personalised recommendations